UBS Group AG provides financial advice and solutions to private, institutional, and corporate clients worldwide. It operates through four divisions: Global Wealth Management, Personal & Corporate Banking, Asset Management, and Investment Bank. The Global Wealth Management division offers investment advice and solutions, and lending solutions. This segment also provides estate and wealth planning, investing, corporate and banking, and investment management, as well as mortgage, securities-based, and structured lending solutions. The Personal & Corporate Banking division provides personal banking products and services, such as deposits, cards, and online and mobile banking, as well as lending, investments, and retirement services; and corporate and institutional solutions, including equity and debt capital markets, syndicated and structured credit, private placements, leasing, traditional financing, trade and export finance, and global custody solutions, as well as transaction banking solutions for payment and cash management. The Asset Management division offers equities, fixed income, hedge funds, real estate and private markets, indexed and alternative beta strategies, asset allocation and currency investment strategies, customized multi-asset solutions, advisory and fiduciary services, and multi-manager hedge fund solutions and advisory services. The Investment Bank division advises clients on strategic business opportunities and helps them raise capital to fund their activities; enables its clients to buy, sell, and finance securities on capital markets and to manage their risks and liquidity; distribute, trade, finance, and clear cash equities and equity-linked products; and offers clients differentiated content on major financial markets and securities. The company was formerly known as UBS AG and changed its name to UBS Group AG in December 2014. UBS Group AG was founded in 1862 and is based in Zurich, Switzerland.

UBS looks like a large and profitable financial institution, but the market is already pricing it at a relatively rich valuation across several key multiples. A P/E of 24.07 is noticeably above the industry median, while a P/B of 1.64 and a P/S of 2.49 are also above average levels, which limits the potential for further re-rating without an acceleration in earnings growth. At the same time, the P/FCF is below the industry median, which partially softens the picture and suggests that cash flow is valued more moderately. The quality of capital returns looks acceptable: ROE of 10.5% and tangible ROE of 10.88% have been improving over the years, but they remain unremarkable relative to the stock’s valuation. ROA of 0.52% and ROI of 2.03% are weak, which for a bank with a very large balance sheet points to low efficiency in asset utilization. Net profit margin of 13.23% and operating margin of 11.67% look stable, but compared with the industry they do not provide a clear advantage. The dividend yield of 1.62% is moderate and has increased over the past several years, but it is not high enough to offset the premium valuation on P/E and P/B. The leverage picture is mixed: debt/equity of 3.84 and long-term debt of 343.6 billion look high, although for a bank this is partly a structural feature of the business rather than purely a risk. Liquidity does not look problematic at a current ratio of 1.10, but the quick ratio is zero, which is typical for the financial sector and requires cautious interpretation. The balance sheet is very large, assets and equity are stable, and TTM net income remains strong, which supports the investment case. However, revenue and operating profit dynamics do not look linearly upward, and that does not allow for an aggressive upward revision of the target valuation. Overall, the fundamentals mostly support the current forecast, but due to the high relative valuation and weak asset efficiency metrics, only a moderate conservative downward adjustment is justified.

UBS Group AG Registered

Сильный индекс, значительно упал. Быки в растерянности.

Strong index, significantly down. The bulls are confused.

Средний индекс, незначительно вырос. Рынок не поддерживает быков.

Medium index, slightly up. The market does not support the bulls.

Слабый индекс, незначительно вырос

UBS is profitable and improving ROE, but it trades at a premium on P/E, P/B, and P/S; high leverage and weak ROA limit re-rating potential.

Key Points
Chainlink released CCIP 2.0 on Sept. 28, months after a $292 million hack on a rival blockchain bridge.
The upgrade lets institutions add their own verifiers on top of Chainlink’s 16-operator network.
Customer fees are converted into LINK and stored in a strategic reserve, which could support the token over time.
On Sept. 28, Chainlink (CRYPTO: LINK) released version 2.0 of its Cross-Chain Interoperability Protocol (CCIP). It's the system that moves tokens and data between blockchains that can't communicate directly. That matters more as banks and asset managers convert stocks, bonds, and funds into tokenized assets that must move across blockchains.
The timing of this upgrade isn't random. In April, attackers allegedly tied to North Korea's Lazarus Group drained about $292 million from Kelp DAO's bridge. That setup ran on Chainlink rival LayerZero and relied on a single verifier, which the attackers fooled. CCIP 2.0 is built to make that kind of failure harder.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
The two-key vault
Picture an old-school bank vault that requires two keys to be turned at once. CCIP 2.0 works a bit like that. Chainlink's default network of 16 independent node operators still has to approve every transfer. Now, institutions can add their own verifiers or hire companies like Infosys and Nethermind to run them. Unless both layers sign off, the money won't move.
The upgrade also bakes in compliance checks (know-your-customer tools, anti-money-laundering processes, sanctions screeners) and lets issuers pick their speed. Small, routine transfers can zip through, while big and important ones wait for full confirmation.
There's one security trade-off. Chainlink's Risk Management Network, a separate set of nodes that used to double-check transactions, no longer fills that role. Users who skip the optional verifiers now rely on one verifier network instead of two.
Chainlink has customers; Cardano is still looking
It's a busy period for blockchain plumbing. Cardano (CRYPTO: ADA) launched its own compliance-focused token standard on Oct. 7. The two cryptos are practically twins by size, with market caps of $9.7 billion for Chainlink and $9.4 billion for Cardano. Their customer lists look nothing alike, though.
Cardano couldn't name a single bank or stablecoin issuer lined up to use its new tools. Chainlink's Rolodex includes the Swift banking network, the Depository Trust & Clearing Corporation (DTCC), UBS, and ANZ Bank. Plenty of those connections are pilot programs and experiments, but CCIP also handles real money. According to Chainlink, it supports more than $84 billion in cross-chain token value.
Even so, the only verifier adopter Chainlink has named is Lombard, a crypto-native Bitcoin yield platform that already used earlier CCIP versions. Chainlink hasn't named any banks or traditional asset managers using the new solution, according to CoinDesk. The extra vault keys have been cut. Hardly anyone is trying to open the locks.
Where LINK comes in
Here's the part LINK holders care about. Chainlink customers can pay in tokens, stablecoins, or even traditional currency, and a system called Payment Abstraction converts those payments into LINK. That LINK goes into a strategic reserve funded by enterprise and on-chain revenue.
More bridge traffic means more fees, and more fees mean more LINK tokens headed for the reserve. On a large scale, the buyback-like process should tip the supply and-demand balance in favor of higher token prices.
LINK investors weren't overly impressed. As of Oct. 8, the token trades at $12.96, down 5.8% from the CCIP 2.0 release and 75.5% below its all-time high from May 2021.
That's the honest scorecard. Chainlink built a sturdier bridge just as the industry was getting scared of flimsy ones. Now it needs the big banks to start driving across it, not just taking test drives.
Should you buy stock in Chainlink right now?
Before you buy stock in Chainlink, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Chainlink wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $375,887!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,459,146!*
Now, it’s worth noting Stock Advisor’s total average return is 955% — a market-crushing outperformance compared to 215% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
Anders Bylund has positions in Cardano and Chainlink. The Motley Fool has positions in and recommends Chainlink. The Motley Fool has a disclosure policy.

Chainlink Just Released a New Version of Its Blockchain Interoperability Protocol. Here's What It Means for LINK Investors.

Monday, October 5, 2026
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Texas Instruments Inc. (TXN), RTX Corp. (RTX) and Marvell Technology, Inc. (MRVL), as well as two micro-cap stocks, Air T, Inc. (AIRT) and GSI Technology, Inc. (GSIT). These research reports have been hand-picked from roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Ahead of Wall Street
The daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens, attempting to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning.
You can read today's AWS here >>> Pre-Markets Down a Tad Following Last Week’s Gains
Today's Featured Research Reports
Texas Instruments’ shares have outperformed the Zacks Semiconductor - General industry over the past year (+61.6% vs. +34.2%). Per the Zacks analyst, the company is benefiting from broadening demand across industrial, data center and automotive markets. Its analog and embedded franchises, internal manufacturing, expanding capacity and CHIPS Act support strengthen long-term growth and supply control. The Silicon Labs acquisition further enhances connectivity capabilities.
However, risks include elevated debt, geopolitical and trade exposure, intense competition, seasonality and higher manufacturing costs.
(You can read the full research report on Texas Instruments here >>>)
RTX’s shares have outperformed the Aerospace - Defense industry over the past year (+9.5% vs. -19.6%). The Zacks analyst believes that the company benefits from commercial aerospace recovery, strong defense demand and a robust backlog. Rising air traffic, OEM and aftermarket sales and engine demand support growth, while strong defense bookings provide further stability.
Yet, supply-chain disruptions and aircraft engine availability could constrain production and deliveries. Tariff uncertainty and Russia-related sanctions also pose operational risks.
(You can read the full research report on RTX here >>>)
Marvell’s shares have outperformed the Electronics - Semiconductors industry over the past year (+206.2% vs. +41.4%). The Zacks analyst believes that the company is benefiting from strong AI-driven data center demand, with custom silicon, interconnect, switching and optics supporting growth. Its expanded NVIDIA partnership and recent acquisitions strengthen its position in hyperscaler infrastructure, while communications demand is recovering.
Yet, profitability remains sensitive to product mix, and the business is concentrated among a limited number of customers. Export controls, tariffs and overseas shipments pose risks, while intense competition could pressure demand and margins.
(You can read the full research report on Marvell here >>>)
Air T’s shares have outperformed the Zacks Transportation - Air Freight and Cargo industry over the last six months (+29.9% vs. -12.0%). The Zacks analyst believes that the company benefits from a diversified aviation platform, improving ground-support profitability, recurring digital revenues, stable cargo operations and expanding asset management. Rex and broader aftermarket and MRO capabilities offer additional growth opportunities.
Risks include Rex fleet restoration, integration challenges, FedEx concentration, weaker digital operations and higher financial obligations. Cash flow and earnings visibility remain concerns.
(You can read the full research report on Air T here >>>)
GSI’s shares have underperformed the Zacks Computer - Storage Devices industry over the past year (+16.4% vs. +270.0%). The Zacks analyst believes that the company faces risks from early-stage commercialization of its Gemini-II APU and lengthy defense procurement cycles that could delay adoption. Dependence on a single foundry and evolving export controls and AI regulations may also constrain growth.
However, the company’s compute-in-memory architecture enables low-latency, power-efficient AI processing for drones, robotics and autonomous systems. Government contracts and customer deployments provide validation, while its SRAM business and strong balance sheet offer flexibility.
(You can read the full research report on GSI here >>>)
Other noteworthy reports we are featuring today include Welltower Inc. (WELL), UBS Group AG (UBS) and Ross Stores, Inc. (ROST).
Mark Vickery
Senior Editor
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>
Today's Must Read
Featured Reports
Permian Resources (PR) to Benefit From Deep Delaware Inventory
The Zacks analyst believes that Permian Resources' deep Delaware inventory supports long-term growth, but weak Waha gas pricing and pipeline constraints may pressure revenue and output over time.
Asset Optimization Aids Smurfit Westrock (SW) Amid Cost Woes
Per the Zacks Analyst, Smurfit Westrock gains from its ongoing asset optimization and business improvement initiatives. However, merger-related costs and cost inflation remain woes.
Ciena's (CIEN) AI-Driven Optical Demand, Backlog to Fuel Growth
Per the Zacks analyst, Ciena is benefiting from accelerating AI-driven optical demand, a growing backlog and multiyear customer commitments, though supply constraints remain a concern.
Senior Housing Demand & Limited New Supply Aid Welltower (WELL)
Per the Zacks analyst, Welltower gains from senior housing demand, limited supply, occupancy gains and ample liquidity. However, high interest expense, partner concentration and execution risks weigh.
Inorganic Growth & Cost Reduction Supports UBS Group AG (UBS)
Per the Zacks analyst, UBS Group's expanded operations via strategic partnerships and acquisitions reflects solid inorganic growth. Cost reduction initiatives further strengthen its financials.
Virtu Financial (VIRT) Gains from Market Making unit, Expenses High
Per the Zacks Analyst, Virtu Financial's Market Making segment is well-poised for growth due to growing retail engagement. However, elevated expenses are putting pressure on its margins.
Ross Stores (ROST) Gains from Broad-Based Demand and Traffic
Per the Zacks analyst, Ross Stores benefits from strong customer demand, high traffic, broad-based category strength and new shopper gain, supporting sustained sales growth and market-share expansion.
New Upgrades
Sublocade Growth and Cost Savings Support Indivior's (INDV) Upside
The Zacks analyst is encouraged by Sublocade's continued growth, market leadership, higher 2026 guidance, cost savings, and an expanding OUD market, which support Indivior's growth prospects.
DSA Business, Strong Solvency Aid Charles River (CRL)
Per the Zacks analyst, the DSA segment holds strong potential for Charles River's long-term growth. Also, a strong balance sheet looks encouraging.
GigaCloud (GCT) Rides on Scaled Marketplace, Disciplined Integrations
Per the Zacks Analyst, a scaled marketplace, improving margin mix, European infrastructure, international scaling and disciplined integrations aid GCT.
New Downgrades
Post Holdings' (POST) Weak Volumes May Pressure Growth and Margins
Per the Zacks analyst, Post Holdings' persistent volume weakness and inflation are likely to pressure margins and overall financial performance.
Weak QSR traffic and Escalating Costs Hurt Middleby (MIDD)
Per the Zacks analyst, Middleby is facing weak quick-service restaurant (QSR) traffic. Rising costs due to higher tariffs, freight expenses and steel surcharges are also a concern for the company.
Eylea HD, Dupixent Fuel Regeneron (REGN) Amid Competitive Pressure
Per the Zacks analyst, robust demand for Eylea HD and higher profit-sharing from Dupixent sales is boost Regeneron's sales. However, Eylea sales remain under pressure.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This innovative software-as-a-service firm upped its user base +22% year over year. That rate is increasing and margins are expanding as AI efficiencies take effect. Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.
Free: See Our Top Stock And 4 Runners Up
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).

Top Analyst Reports for Texas Instruments, RTX & Marvell

Key Points
Ethereum is the world's largest platform for developing decentralized software applications, which are popular in industries like gaming and financial services.
Tom Lee, chairman of Bitmine Immersion Technologies, thinks Ethereum's native cryptocurrency, Ether, is poised for a major gain.
Lee predicts Ether will eventually reach $250,000 per coin, but his forecast is a little self-serving.
Cryptocurrencies are experiencing a broad rally right now, but most of the industry's major coins are still down significantly from their all-time highs. Ethereum's native cryptocurrency, Ether (CRYPTO: ETH), is trading for almost $2,700 (as of Sept. 25), which is still 46% below last year's peak of $4,846.
But Tom Lee, Wall Street analyst and chairman of Bitmine Immersion Technologies (NYSE: BMNR), thinks investors should consider buying Ether. While speaking at the Proof of Talk conference back in June, he highlighted a series of tailwinds that could spark a rally to $250,000 per coin, representing an eye-popping 9,159% gain from its current price. He didn't provide a timeframe for his forecast, but will it ever become a reality?
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
How Ethereum works
Ethereum is a platform for developing decentralized software applications, which are increasingly popular in industries like gaming and financial services. Each app is governed by slivers of computer code called smart contracts that enforce its rules. Smart contracts live on the Ethereum blockchain and they typically can't be changed, so no person or entity can manipulate an app's core functions, ensuring it remains fully decentralized.
The Ethereum network is also fully decentralized. Thousands of nodes (computers) around the world store an updated copy of its blockchain, so the broader network won't be compromised even if some nodes experience an outage. As a result, Ethereum has maintained 100% uptime during the past decade. This wouldn't have been possible if the network was hosted in a single data center instead, because even the best infrastructure providers typically promise an uptime of just 99.9%.
Ether is the gas that keeps the network running. Whenever someone uses an Ethereum-based decentralized app, a smart contract is activated, and the person must pay a fee in Ether to cover computer processing costs. Therefore, demand for Ether increases organically as the network becomes more heavily used, which should lift the value of each coin.
Ethereum is entering a new era, driven by tokenization and artificial intelligence
In the past, Ethereum was mostly used to build cryptocurrency applications and create non-fungible tokens (NFTs), but Tom Lee thinks the platform is quickly maturing from those obscure use cases. He says it will gradually enter the mainstream economy where it will be used to build payment rails and even settlement infrastructure for transactions conducted by artificial intelligence (AI) agents, which can take actions with minimal human input.
Financial institutions like BlackRock, JPMorgan Chase, and UBS Group have already launched tokenized investment funds that trade on Ethereum-based blockchains instead of traditional stock exchanges. Billions of dollars have flowed into these funds so far, which are used to buy secure assets like U.S. Treasury bonds.
Robinhood Markets (NASDAQ: HOOD) built a Layer-2 blockchain on top of Ethereum called Robinhood Chain. The company is tokenizing real stocks to let clients trade popular securities like Nvidia and Tesla outside of regular market hours. To be clear, investors don't have legal ownership of the underlying stocks when they buy tokenized securities, but they still benefit from any potential upside in exactly the same way.
AI agents can also buy and sell tokenized securities on behalf of their human operators through Robinhood Chain, which could significantly boost transaction volumes in the long term. Speaking more broadly, these agents could eventually have their own money, and a trusted, secure, and decentralized network like Ethereum could be perfect for processing their transactions.
Is Lee's $250,000 target achievable?
A little more than 122 million Ether coins are in circulation as I write this, so at the current price of $2,700 per coin, the ecosystem has a market capitalization of $328 billion. Simple math suggests that a price of $250,000 per coin would result in a market cap of $30.5 trillion, which is almost equal to the output of the entire U.S. economy. It would also make Ethereum more than five times as valuable as the world's largest company, Nvidia, which is currently valued at $5.4 trillion.
If Ethereum eventually finds itself at the center of the financial system, then Lee's $250,000 price target might be achievable. However, despite growing adoption by major financial institutions, the network still has just 2.3 million daily active wallet addresses across its primary blockchain and all Layer-2 blockchains, which is down significantly from its peak of almost 4 million last year.
On a positive note, Robinhood Chain is experiencing a surge in adoption which could lift overall usage numbers. But generally speaking, it seems most consumers aren't very keen to participate in the tokenized economy just yet. I'm not sure what will convince them, but this presents a real challenge for Lee's $250,000 target.
It's important to remember that Lee is the chairman of Bitmine Immersion Technologies, which currently owns 6 million Ether coins, or nearly 5% of all circulating supply. The company's position is worth more than $16 billion, but that would grow to an eye-popping $1.5 trillion if Ether hits $250,000 per coin, so Lee's forecast is definitely a little self-serving.
Should you buy stock in Ethereum right now?
Before you buy stock in Ethereum, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Ethereum wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $383,680!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,382,954!*
Now, it’s worth noting Stock Advisor’s total average return is 937% — a market-crushing outperformance compared to 214% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of September 27, 2026.
JPMorgan Chase is an advertising partner of Motley Fool Money. Anthony Di Pizio has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends BlackRock, Ethereum, JPMorgan Chase, Nvidia, and Tesla. The Motley Fool has a disclosure policy.

1 Popular Cryptocurrency to Buy Before It Soars by 9,159%, According to Bitmine's Tom Lee

Key Points
Argenx's Vyvgart franchise enjoys strong sales momentum.
The company has multiple registrational data read-outs on the way.
Not every Wall Street analyst likes Argenx, but most analysts do.
Even with a recent pullback, Argenx (NASDAQ: ARGX) stock remains a solid winner in 2026. Its shares are up roughly 14% year-to-date, with most of the gains coming over the last three months.
Wall Street thinks that Argenx has plenty of room to run. The consensus 12-month price target for the stock indicates a potential 23% upside. Here's exactly why analysts remain bullish about this biotech stock.
Missed AI’s "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our analysts, we’re only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »
Undeniable (and arguably unstoppable) momentum
I'd rank Argenx's undeniable business momentum as the top reason for Wall Street's bullish view about the stock. Argenx has delivered 18 consecutive quarters of revenue growth.
The company's global product net sales skyrocketed 60% year over year in the second quarter of 2026 to $1.5 billion. Even more impressive, in my opinion, is that sales jumped 17% quarter over quarter.
Argenx's Vyvgart franchise, which includes Vyvgart Hytrulo, continues to rack up commercial success in treating generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), both of which are chronic autoimmune disorders. Vyvgart is also approved in Japan for the treatment of primary immune thrombocytopenia (ITP).
The biggest factor behind Argenx's recent surge in growth is the U.S. Food and Drug Administration (FDA) approval of a label expansion for Vyvgart and Vyvgart Hytrulo in May 2026. This FDA decision made the therapies the first and only approved treatments for all serotypes of adults with gMG. Physicians now have a single treatment option for all their adult gMG patients.
However, CIDP is also an important growth driver for Argenx. Around 24,000 patients are being treated today for CIDP in the U.S., but roughly half of them aren't viewed as well-managed on their current therapy. Vyvgart was the first innovation in CIDP treatment in the last three decades.
Coming catalysts
Analysts also know that Argenx has several potential catalysts on the way. Several of them could move the needle significantly for this growth stock.
The company reported positive results from its Phase 3 study evaluating Vyvgart in ocular myasthenia gravis (oMG) earlier this year. CEO Karen Massey said in the Q2earnings call "We're moving forward with urgency on [the] ocular MG filing." There are currently no advanced therapies approved for oMG.
Argenx's positive results from another late-stage study of Vyvgart Hytrulo in treating chronic inflammatory disorder autoimmune myositis lay the foundation for another regulatory filing. Vyvgart Hytrulo was especially impressive in treating a type of autoimmune myositis called immune-mediated necrotizing myopathy (IMNM), which has no approved therapies.
The company plans to announce results in the fourth quarter of 2026 from a registrational study of empasiprubart for the treatment of multifocal motor neuropathy (MMN). Results from four registrational studies are expected next year: two for Vyvgart and two for empasiprubart.
One outlier on Wall Street
Twenty analysts rate Argenx as a "buy." Some are especially upbeat about the stock. For example, Wells Fargo's (NYSE: WFC) Derek Archila thinks Argenx could soar another 47% over the next 12 months. UBS (NYSE: UBS) analyst Xian Deng's price target reflects a 45% upside.
However, there isn't unanimous excitement on Wall Street about the biotech stock. One outlier, Colleen M. Kusy at Robert W. Baird, recommends holding rather than buying Argenx. Kusy's 12-month price target is even slightly below the current share price.
Why would any analyst be less than enthusiastic about Argenx? The company has a lot riding on its upcoming clinical data. The risks of disappointing results can't be overlooked.
At first glance, valuation might seem to be a concern, with Argenx's trailing 12-month price-to-earnings ratio of 36. I don't think this is worrisome, though, considering the company's strong growth. Argenx's price-to-earnings-to-growth (PEG) ratio, which incorporates analysts' five-year growth estimates, is a much more attractive 1.15.
Most analysts remain optimistic about Argenx due to the robust momentum of its Vyvgart franchise and near-term pipeline catalysts. I agree that the stock should have significant upside.
Should you buy stock in Argenx Se right now?
Before you buy stock in Argenx Se, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Argenx Se wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $386,781!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,379,943!*
Now, it’s worth noting Stock Advisor’s total average return is 936% — a market-crushing outperformance compared to 213% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of September 26, 2026.
Wells Fargo is an advertising partner of Motley Fool Money. Keith Speights has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Argenx Se. The Motley Fool has a disclosure policy.

Here's Exactly Why Wall Street Thinks Argenx Stock Could Soar 23% Over the Next 12 Months

HSBC Holdings HSBC is sharpening its growth strategy around businesses where it already has scale and competitive advantages, while using exits and simplification savings to fund expansion.
Last week, at the Barclays Global Financial Services Conference, chief financial officer Pam Kaur said that all four of HSBC’s businesses are growing and generating returns above the minimum targets set earlier this year. The company’s near-term investment priorities include Hong Kong, wealth management, data and AI, U.K. small and midsize enterprises, and wholesale transaction banking across foreign exchange, trade, payments and securities services.
Hong Kong, Wealth and Trade Drive HSBC’s Expansion
Hong Kong remains central to the bank’s expansion plan. HSBC’s franchise there continues to benefit from customer acquisition, cross-border flows and wealth activity. Pam Kaur mentioned new-to-bank customer additions in July and August remained around the first-half average, while second-quarter net new money in wealth reached $22 billion, equivalent to an annualized growth rate of 8%. This builds on HSBC’s already sizable Hong Kong franchise, where it added more than 1.1 million new-to-bank customers and opened five new Wealth Centers in 2025. The full ownership of Hang Seng Bank is likely to deepen that position. Management expects about $900 million of value creation from synergies, while Hang Seng’s new-to-bank customer flow doubled in the second quarter.
Trade finance is another expansion engine. HSBC said Asian export growth is supporting stronger demand for short-term commercial lending as clients adjust supply chains. Trade loans rose 30% year over year to $120 billion, while trade revenues increased 13% to $800 million in the second quarter. In the U.K., HSBC is focusing investment on SME banking, trade, international banking and technology-led customer journeys. The ring-fenced U.K. bank generated a 21% return on tangible equity, with revenue up 5%, lending up 7% and deposits up 4%.
Importantly, HSBC is trying to self-fund much of this expansion. The bank has announced 15 business or market exits since the start of 2025. Those businesses represent roughly $1.1 billion of costs and about $2 billion of revenue. Management intends to redeploy the released cost base into higher-return core businesses, though the revenue drag will arrive faster than some reinvestment benefits. HSBC also raised its organizational simplification savings target to $2 billion from $1.5 billion. The strategy is therefore less about broad geographic expansion and more about concentrating capital, technology and talent in franchises with stronger returns.
The financial backdrop supports that approach. HSBC reiterated its target for revenue growth to rise to 5% year over year by 2028 and for return on tangible equity of at least 17% through 2028, excluding notable items. It also lifted 2026 banking net interest income guidance to at least $46 billion.
Capital generation remains strong, giving HSBC considerable flexibility in how it deploys excess resources. Management has maintained a clear capital-allocation hierarchy, with a 50% dividend payout ratio as the first priority, followed by investment in organic growth opportunities that can generate attractive returns within the bank’s risk appetite. Beyond those needs, HSBC continues to favor share buybacks as its preferred method of returning surplus capital to shareholders, supporting both shareholder distributions and per-share value creation while preserving capacity to fund growth.
Can HSBC Shares Extend Their Rally?
HSBC’s shares have delivered a strong performance so far this year, gaining 31.2% and outperforming the industry’s 19.1% rise. The stock has also fared better than peers such as Barclays BCS and UBS Group AG UBS, which declined 0.6% and gained 10.2%, respectively, over the same period.
With HSBC closing within about 5% of its 52-week high in the latest trading session, some of the optimism surrounding its growth strategy may already be reflected in the share price.
Despite the impressive rally, HSBC’s valuation remains reasonable. The stock is currently trading at a forward 12-month price-to-earnings (P/E) multiple of 10.93X, slightly below the industry average of 11.19X. The below-industry valuation suggests the stock’s strong year-to-date gains have not pushed its multiple significantly above sector levels, making the valuation supportive if operating momentum continues.
P/E F12M
Among its peers, Barclays trades at a forward 12-month P/E multiple of 7.84X, while UBS Group trades at 11.81X. Thus, HSBC commands a substantial premium to Barclays but remains less expensive than UBS Group.
The earnings outlook also remains supportive. The Zacks Consensus Estimate for HSBC’s 2026 earnings indicates a 13.4% year-over-year increase, while earnings in 2027 are expected to rise another 14.2%. Over the past 30 days, the consensus estimate for 2026 earnings has edged down to $8.56 per share, while the 2027 estimate has moved slightly higher to $9.77.
Earnings Estimates
Further upside in HSBC shares will likely depend on the bank’s ability to sustain wealth inflows, successfully integrate Hang Seng Bank and maintain healthy growth across trade finance and U.K. lending. Progress toward its cost-saving targets and evidence that investments in core businesses can offset revenues lost through market exits would further strengthen the earnings outlook.
At the same time, execution risks remain. HSBC faces potential pressure from interest-rate volatility, credit deterioration in selected portfolios and the timing gap between revenue lost through exits and returns from reinvestment. The strong rally in the stock also raises the bar for future results, making consistent delivery against management’s revenue growth, return and cost targets increasingly important.
Overall, HSBC’s operating momentum, earnings growth prospects and relatively reasonable valuation provide support to the investment case. However, with the shares already trading near their 52-week high, the next leg of the rally will likely depend on management translating its focused expansion strategy into sustained earnings growth while maintaining cost and capital discipline.
At present, HSBC carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Radical New Technology Could Hand Investors Huge Gains
Quantum Computing is the next technological revolution, and it could be even more advanced than AI.
While some believed the technology was years away, it is already present and moving fast. Large hyperscalers, such as Microsoft, Google, Amazon, Oracle, and even Meta and Tesla, are scrambling to integrate quantum computing into their infrastructure.
Senior Stock Strategist Kevin Cook reveals 7 carefully selected stocks poised to dominate the quantum computing landscape in his report, Beyond AI: The Quantum Leap in Computing Power.
Kevin was among the early experts who recognized NVIDIA's enormous potential back in 2016. Now, he has keyed in on what could be "the next big thing" in quantum computing supremacy. Today, you have a rare chance to position your portfolio at the forefront of this opportunity.
See Top Quantum Stocks Now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
UBS Group AG (UBS) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).

HSBC Targets Higher-Return Growth: Can the Stock Keep Climbing?

Key Points
Wells Fargo and UBS have 12-month price targets for Argenx that are more than 40% above the current share price.
Argenx's momentum and clinical successes appear to justify these lofty expectations.
Argenx (NASDAQ: ARGX) has been a solid winner for investors over the last 12 months, with its shares rising by roughly 30%. Wall Street thinks that the biotech stock can go even higher. The consensus one-year price target for Argenx reflects a potential upside of around 20%.
Two analysts, though, are even more bullish. Wells Fargo's (NYSE: WFC) Derek Archila and UBS' (NYSE: UBS) Xian Deng predict that Argenx's share price can soar more than 40% over the next 12 months. Here's why they're probably right.
Missed AI’s "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our analysts, we’re only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »
Three cheers for Argenx
Financial growth usually leads to share price appreciation. Argenx has delivered 18 consecutive quarters of revenue growth. Even better, its momentum is accelerating. In the second quarter of 2026, the company reported 60% year-over-year sales growth. Its revenue jumped 16% from the previous quarter.
What about Argenx's bottom line? The improvement is even more impressive. The drugmaker's earnings nearly doubled in Q2, soaring 93% year over year.
Another reason to cheer for Argenx is its recent pipeline success. On Aug. 17, 2026, Argenx reported positive results from its late-stage Alkivia study evaluating Vyvgart Hytrulo in adults with autoimmune myositis, a chronic inflammatory and muscular disease. This was the first Phase 3 clinical trial to achieve statistically significant improvement for immune-mediated necrotizing myopathy (IMNM), a type of autoimmune myositis for which there are no approved therapies.
Argenx's Alkivia results, though, underscore a third -- and most compelling, in my view -- reason why the bullish targets from Wells Fargo and UBS analysts for the biotech stock are justified. Vyvgart and Vyvgart Hytrulo have now proven themselves across four distinct autoimmune diseases. This track record makes it easy to be optimistic about Argenx's chances of success in targeting other indications. More growth could realistically be on the way.
Potential flies in the ointment
A few things could get in the way of Argenx's share price rising by 40% or more over the next 12 months. For one thing, the company's revenue is generated entirely by its Vyvgart franchise. Any hiccup could derail Argenx's momentum.
Argenx's stock would also sink if it experiences a clinical setback. Investors will be especially watching upcoming late-stage results for empraisprubart in multifocal motor neuropathy in Q4 and in chronic inflammatory demyelinating polyneuropathy (CIDP) in the second half of 2027.
Also, a broader stock market meltdown usually pulls down even the best growth stocks. Argenx could continue to rack up commercial and pipeline successes yet still not jump as much as Wells Fargo and UBS expect, due to market headwinds.
Still, though, I think Argenx's growth prospects are bright. Wall Street's optimism is warranted.
Should you buy stock in Argenx Se right now?
Before you buy stock in Argenx Se, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Argenx Se wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $387,158!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,365,749!*
Now, it’s worth noting Stock Advisor’s total average return is 932% — a market-crushing outperformance compared to 211% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of September 20, 2026.
Wells Fargo is an advertising partner of Motley Fool Money. Keith Speights has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Argenx Se. The Motley Fool has a disclosure policy.

2 Wall Street Analysts Think Argenx Can Soar More Than 40%. Here's Why They're Right.

Credit Acceptance Corporation CACC reached a settlement with the New York Attorney General and 40 other state attorneys general, resolving litigation and a multistate investigation into its subprime auto-lending practices.
As part of the agreement, CACC will eliminate outstanding balances for more than 55,000 eligible consumers nationwide, resulting in more than $630 million in debt relief. The company will also contribute $60 million to a consumer relief fund for additional consumers who lost their vehicles to repossession. Participating attorneys general will administer the fund. Additionally, the company will pay a penalty of $15.5 million to the states.
The settlement was reached without an admission of fault or wrongdoing by Credit Acceptance. The company noted that the monetary components of the resolution will not require additional charges beyond amounts previously accrued and disclosed in its financial statements.
CACC’s New Consumer and Dealer Protections
CACC will supplement its existing controls with additional requirements covering vehicle pricing, ancillary products, loan affordability and dealer oversight. For certain at-risk borrowers who default within 12 or 18 months and subsequently have their vehicles repossessed and sold, the company will forgive 95% of the remaining debt and may collect only the remaining 5%.
The company will also be required to contact consumers outside the dealership showroom to provide clearer information about ancillary products and offer a process to cancel unwanted products while retaining their vehicles. These measures will increase oversight of Credit Acceptance's lending and dealer practices and provide greater clarity around regulatory expectations.
Our Take on Credit Acceptance
The settlement resolves a longstanding legal and regulatory matter for CACC while establishing additional requirements for its consumer-lending and dealer-oversight practices. The company said the provisions are broadly consistent with regulatory expectations in the automotive finance industry and do not fundamentally alter its business model.
The absence of additional charges beyond amounts previously accrued will likely limit the settlement's immediate financial impact. However, the enhanced requirements around loan affordability, ancillary products, and dealer oversight are expected to affect how CACC manages its subprime lending operations and dealer relationships in the future. The company will need to balance compliance with these measures while continuing to serve subprime consumers.
Over the past six months, Credit Acceptance’s shares have rallied 31.3% compared with the industry’s 13.4% growth.
6-Month Price Performance
Currently, Credit Acceptance carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Other Financial Firms’ Progress in Fixing Litigation Issues
In June 2026, Franklin Templeton, Inc.’s BEN subsidiary Western Asset Management Company agreed to pay a $100 million civil penalty to settle the Securities and Exchange Commission (SEC) charges related to alleged trade-allocation misconduct by its former co-chief investment officer Kenneth Leech. The penalty will be distributed to affected investors through a Fair Fund, while Western Asset neither admitted nor denied the SEC’s findings.
The settlement resolves a major regulatory matter surrounding Western Asset’s alleged cherry-picking of U.S. Treasury derivative trades between January 2021 and October 2023. The resolution concludes investigations by the SEC and the Department of Justice (DOJ), removing a significant regulatory overhang for Franklin Resources. This would allow BEN to focus on strengthening compliance controls, retaining client assets and restoring investor confidence.
In May 2026, the Federal Reserve officially terminated its 2023 enforcement actions against UBS Group AG UBS tied to the collapse of Archegos Capital Management in 2021. The move marks the closure of one of the major enforcement matters inherited by UBS following its emergency acquisition of Credit Suisse in 2023.
The termination of the Fed’s Archegos-related enforcement action represents another milestone in UBS’ broader regulatory remediation efforts. The removal of this regulatory overhang could support UBS’ long-term integration efforts, profitability, and operational efficiency as the company continues to address legacy Credit Suisse matters.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.
Free: See Our Top Stock And 4 Runners Up
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
UBS Group AG (UBS) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).

What's Next for CACC After Its Multistate Lending Settlement?

Key Points
Micron Technology is a leading supplier of high-bandwidth memory for AI workloads.
Memory prices are skyrocketing because of a severe supply-demand imbalance.
Micron stock looks cheap by one traditional valuation metric, but that doesn't necessarily mean it will move higher.
Micron Technology (NASDAQ: MU) stock closed at $958.73 on Monday, Aug. 31, which was 21% below its June all-time high. But just to keep things in perspective, the stock is still sitting on an eye-popping one-year gain of 680%.
Micron supplies some of the world's best high-bandwidth memory (HBM) for data centers, a critical component in the artificial intelligence (AI) hardware stack. Demand is currently through the roof and supply remains tight, giving the company an unprecedented ability to dictate prices.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
However, the supply-demand imbalance could resolve during the next year or two, potentially hurting Micron's financial performance. Therefore, although its stock is trading at a very attractive valuation, it isn't a straightforward buy right now. Here's why I'm steering clear despite the recent dip.
Why Micron stock is pulling back
According to Nvidia, the five largest hyperscale companies (which includes the likes of Microsoft and Amazon), will spend nearly $800 billion combined on AI data center infrastructure during 2026, with a substantial chunk of that money going toward chips and components. Nvidia says that spending figure could top $1.3 trillion in 2027.
Those companies have to earn a return on all of that spending; otherwise, it won't make economic sense. Some of them will make money by renting computing capacity to other businesses for a fee, whereas others will charge for the use of their AI models and software applications. But making money isn't easy with hardware costs surging; a recent report by Bloomberg suggests Nvidia has informed customers of a 15% price increase, partly because of rising HBM prices.
To recoup some of the climbing costs, companies like Microsoft and Anthropic recently implemented passive price increases for the use of their AI models and software, which has forced some organizations to rethink their spending. Uber Technologies, Walmart, AT&T, and Amazon are just some of the companies that have implemented AI usage caps on their employees to prevent budget blowouts.
According to a recent survey by UBS Group, about 60% of businesses are now routing tasks to cheaper, more efficient AI models to help reduce usage costs. These models typically consume less computing power, which might be bad news for semiconductor demand.
To make matters worse, lawmakers in more than a dozen U.S. states have introduced legislation to temporarily ban the construction of new data centers while they weigh the social, economic, and environmental impacts. This will be a problem for many planned infrastructure projects, and the effects could flow through to Micron and other chip makers in the form of lower sales.
Micron's revenue continues to skyrocket
The aforementioned AI headwinds haven't shown up in Micron's financial results. The company generated a record $41.4 billion in total revenue during its fiscal 2026 third quarter (ended May 28), a staggering 346% increase from the year-ago period. All four segments of its business produced triple-digit percentage growth, thanks to AI-related memory demand for data centers, computers, smartphones, and even cars.
The supply-demand imbalance in the memory market is giving Micron an unprecedented ability to dictate prices, which is a big reason for its rapid revenue growth. That is also boosting the company's profit margins, which is why its third-quarter earnings soared by an eye-popping 1,368% to $24.67 per share.
Management's forecast points to another set of blockbuster results in the fourth quarter, which just ended on Aug. 31. The company is expected to have $50 billion in sales and earnings of $30.73 per share. The final numbers will be revealed at the end of September.
Why I'm not buying Micron stock on the dip
Micron stock looks like an absolute bargain right now. Based on the company's trailing 12-month earnings of $44.23 per share, its stock is trading at a price-to-earnings (P/E) ratio of just 21, making it cheaper than both the S&P 500 and Nasdaq-100 indexes, which have P/E ratios of 24.5 and 34.3, respectively.
Plus, if Micron's earnings rise to $155.03 per share in fiscal 2027 like Wall Street expects (according to Yahoo! Finance), then its stock has an even more attractive forward P/E ratio of just 6.
Why would a company growing at Micron's pace be trading at a discount to the broader market? Simply put, I think Wall Street knows the company's earnings will eventually crash back down to Earth. If a slowdown in demand doesn't cause it, then an increase in supply might, because every memory company is racing to build more manufacturing capacity right now. During the next few years, higher supply levels will erode Micron's ability to dictate prices, so the company probably won't be able to maintain its current level of earnings.
As a result, if we look a few years into the future, Micron stock might be more expensive than it currently appears. That's why I don't plan to buy the recent dip.
Should you buy stock in Micron Technology right now?
Before you buy stock in Micron Technology, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Micron Technology wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $435,803!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,334,577!*
Now, it’s worth noting Stock Advisor’s total average return is 966% — a market-crushing outperformance compared to 211% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of September 3, 2026.
Anthony Di Pizio has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Amazon, Micron Technology, Microsoft, Nvidia, and Walmart. The Motley Fool recommends Uber Technologies. The Motley Fool has a disclosure policy.

Micron Technology Stock Has Stumbled, but Here's Why I'm Not Buying the Dip

Key Points
Interactive Brokers was downgraded to neutral from buy.
The analyst calls the company "best-in-class" but thinks the stock has gotten ahead of itself.
Interactive Brokers' track record illustrates why it's worthy of a premium.
Shares of Interactive Brokers Group (NASDAQ: IBKR) slipped on Tuesday, falling as much as 6.3%. As of 2:18 p.m. ET, the stock was still down 6%.
The catalyst that drove the brokerage and trading platform lower was bearish commentary by one of Wall Street's finest.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Fully baked?
UBS analyst Michael Brown downgraded Interactive Brokers to neutral (hold) from buy, though he increased his price target to $102, up from $50. That represents potential upside for investors of roughly 5% compared to Monday's closing price -- so he's clearly playing catch-up.
Brown appears to have mixed feelings about the stock. One the one hand, the analyst views Interactive Brokers as "a best-in-class broker with a compelling growth runway." He expects the company to generate low-teens earnings per share (EPS) growth over the coming five years, fueled by account and client asset growth and increased trading activity. The analyst also called the platform "highly efficient," which will allow Interactive Brokers to maintain its gross margin in the high 70% range.
The analyst also cited a suite of new products -- including cryptocurrency, prediction markets, and advanced tools -- which he believes will deepen both customer engagement and wallet share.
So what's not to like? Brown says the current stock price "already reflects much of that advantage."
The analyst has a point. As of market close yesterday, Interactive Brokers stock was trading for nearly 39 times earnings and 36 times forward earnings. While that's not particularly egregious, the valuation is a bit stretched for a company expected to grow earnings by low double digits.
On the other hand, Interactive Brokers' stock is up 47% over the past year, well ahead of the 18% gains of the S&P 500. In fact, the stock has far outpaced the broader market over the past three and five years -- which helps illustrate why Interactive Brokers is deserving of a premium.
Should you buy stock in Interactive Brokers Group right now?
Before you buy stock in Interactive Brokers Group, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Interactive Brokers Group wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $437,097!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,355,077!*
Now, it’s worth noting Stock Advisor’s total average return is 978% — a market-crushing outperformance compared to 213% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of September 1, 2026.
Danny Vena, CPA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Interactive Brokers Group. The Motley Fool recommends the following options: long January 2027 $43.75 calls on Interactive Brokers Group and short January 2027 $46.25 calls on Interactive Brokers Group. The Motley Fool has a disclosure policy.
Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a multimedia financial-services company dedicated to building the world's greatest investment community. Reaching millions of people each month through its website, books, newspaper column, radio show, television appearances, and subscription newsletter services, The Motley Fool champions shareholder values and advocates tirelessly for the individual investor. The company's name was taken from Shakespeare, whose wise fools both instructed and amused, and could speak the truth to the king -- without getting their heads lopped off.

Why Interactive Brokers Stock Tumbled on Tuesday

Wells Fargo & Company WFC is stepping up efforts to expand its wealth management business by recruiting hundreds of independent financial advisers, according to a Bloomberg report published by Yahoo Finance. The hiring push builds on the bank’s multi-year effort to strengthen its Wealth & Investment Management (WIM) division and deepen relationships with affluent and high-net-worth clients.
WFC has been revamping its WIM business since 2020, when it reorganized its operations into five major business lines. WIM offers wealth management, brokerage, financial planning, lending, private banking, trust and fiduciary services to affluent, high-net-worth and ultra-high-net-worth clients. This broad offering enables the bank to address multiple financial needs, deepen client relationships and generate more revenue from wealthy customers beyond traditional banking activities.
Expanding its independent adviser network is a key part of this strategy. Independent advisers are becoming an increasingly important growth channel as financial professionals seek greater control over their practices while retaining access to institutional technology, investment products and infrastructure. WFC’s model gives advisers greater flexibility while allowing them to leverage the bank’s resources.
The bank is also strengthening its adviser capabilities through expanded investment offerings and technology. In May 2026, WFC launched Advisor Gateway, giving advisers one-click access to more than 200 tools and applications, including BlackRock’s Aladdin Wealth technology and generative AI capabilities. Last year, WIM added alternative investments to its Personalized Unified Managed Account program in collaboration with InvestCloud, enabling qualifying clients to hold traditional and alternative assets in a single account. These enhancements are expected to help WFC attract more advisers and assets, improve productivity and capitalize on growing demand for alternative investments.
The wealth management push also aligns with WFC’s broader strategy under CEO Charlie Scharf. Since 2019, the bank has been exiting non-core and lower-return operations to focus resources on its core, higher-return businesses. Meanwhile, the company has been expanding across multiple business lines since the Federal Reserve lifted the asset cap that had constrained its growth since 2018. Reallocating resources toward higher-return businesses, including wealth management, will likely support growth in fee-based recurring revenues, client assets, deposits and lending. However, successful execution will be key to driving sustainable growth and higher returns.
How Are WFC Peers Scaling Wealth Management Business?
Similar to WFC, UBS Group UBS and Morgan Stanley MS are strengthening wealth management operations through acquisitions, partnerships and technology investments to expand capabilities, deepen client relationships and diversify revenues.
UBS Group has strengthened its wealth franchise through the acquisition and integration of Credit Suisse, while expanding its private-market capabilities through a partnership with MSCI. UBS Group also received a U.S. national bank charter for UBS Bank USA in March 2026, supporting its banking and wealth management offerings.
Similarly, Morgan Stanley has expanded wealth and investment management businesses through acquisitions, including E*TRADE Financial and Eaton Vance. The businesses accounted for nearly 54% of total net revenues in 2025, up from 26% in 2010, highlighting the growing contribution of wealth and investment management to Morgan Stanley’s overall business mix.
WFC’s Price Performance, Valuation & Estimates
Shares of Wells Fargo have gained 3.4% in the past year compared with the industry’s growth of 22%.
From a valuation standpoint, WFC trades at a forward price-to-earnings (P/E) ratio of 11.03X, below the industry’s average of 14X.
Price-to-Earnings F12M
The Zacks Consensus Estimate for WFC’s 2026 and 2027 earnings implies year-over-year increases of 15.5% and 9.5%, respectively. Estimates for both years have been revised marginally upward over the past month.
Estimate Revision Trend
WFC currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Beyond Nvidia: AI's Second Wave Is Here
The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.
See Stocks Now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
UBS Group AG (UBS) : Free Stock Analysis Report

Indicator	Jun 26	Jul 26	Aug 26	Sep 26	Oct 26	TTM	Median
P/E	18.22	—	—	24.07	17.20	17.20	12.91
Price/Sales	2.39	2.49	—	—	2.26	2.26	2.16
P/B	—	1.80	—	1.64	1.60	1.60	1.22
P/FCF	—	8.81	9.31	—	—	9.31	10.38

Indicator	Jun 26	Jul 26	Aug 26	Sep 26	Oct 26	TTM	Median
ROE	9.87	—	—	—	—	9.87	11.06
ROA	0.54	—	—	—	—	0.54	1.27
ROI	2.09	—	—	—	—	2.09	7.63
Net Worth	158.74	168.93	—	154.16	149.87	149.87	1.01
Quick Ratio	0.00	—	—	—	—	0.00	1.42
Current Ratio	1.10	—	—	—	—	1.10	0.98

Indicator	Jun 26	Jul 26	Aug 26	Sep 26	Oct 26	TTM	Median
Net Profit Margin	13.07	—	—	—	—	13.07	17.62
Operating Margin	11.65	—	—	—	—	11.65	25.00
Gross Margin	71.14	—	—	—	—	71.14	71.98
Return on tangible equity	10.69	—	—	—	—	10.69	12.85

UBS Group AG Registered

Recent quarterly and TTM performance

Valuation

Debts

Efficiency

Other ratios

Revenue

Indicator	Jun 26	Jul 26	Aug 26	Sep 26	Oct 26	TTM	Median
EPS	0.87	0.87	—	—	—	0.87	0.71
EPS Forecast	0.90	0.90	—	—	—	0.90	0.73
Revenue	11.30B	—	—	—	—	11.30B	90.00M
Gross Profit	11.30B	—	—	—	—	11.30B	—
EBITDA	—	—	—	—	—	0.00	—